Title Date Documents

RXi Q3 2016 Earnings Conference Call Transcript

RXi Presents at BIO Investor Forum 2016

RXi Presents at 16th Annual Biotech in Europe Forum Global Partnering & Investment Event

Self-Delivering RNAi Compounds (sd-rxRNA®) for the Treatment of Ocular Disorders - Presented at: 4th Annual Targeting Ocular Disorders Conference

BioPharm America™ International Partnering Conference

RXi Q2 2016 Earnings Conference Call Transcript

Diphenylcyclopropenone Ointment for the Treatment of Common Warts - Presented at: 2016 Summer Meeting of the American Academy of Dermatology (AAD)

Poster 582 Potent Self-delivering RNAi Compounds Targeting MMP1 Reduce UVR Induced MMP1 Upregulation - Presented at: Society for Investigative Dermatology (SID) 75th Annual Meeting

RXi Q1 2016 Earnings Conference Call Transcript

Non-clinical Development of RXI-109 to Support Clinical Investigation in Dermal Indications – Presented at: 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference